Delivery Order SPE2DR25D1103-SPE2DR26FE620
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,486.64 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol Eye Drops (10ml) on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger prime contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,594.95 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol Eye Drops (10ml) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December...
- The Defense Logistics Agency (DLA) awarded a $1,103.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml), with an ultimate completion date of November 19, 2025. This delivery order, issued on November 18, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,896.48 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) under a firm fixed-price contract. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ML quantities, with a ceiling value of $7,944.73 and a firm fixed price structure. This contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 22, 2025. The award was issued to AmerisourceBergen's Corporate Office division, based in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $4,258.38 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $13,261.23 delivery order to AmerisourceBergen Drug Corp for dorzolamide-timolol eye drops (10mL) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price, non-set-aside contract utilizing a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dorzolamide-Timolol eye drops (10ml) with a contract ceiling value of $1,318.75. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ml quantities under a firm fixed-price contract valued at $4,762.14. This delivery order, which carries a completion date of November 21, 2025, represents a non-set-aside competitive award and serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $1,110.96 delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, indicating the award was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE620Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol Eye Drops (10ml) on January 5, 2026, with a ceiling value of $1,058.54 and an ultimate completion date of January 6, 2026. This competitively awarded, non-set-aside delivery order employs firm fixed price pricing and represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The place of performance is AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 billion through December 2026. As a prime contractor on this IDC, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency. The relatively small-value order for eye drops reflects the routine nature of DLA's ongoing medical supply chain operations, drawing from the contractor's extensive portfolio of medications across multiple therapeutic domains to support federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/4/26 |